Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
Phase I pharmacokinetics study of high-dose fotemustine and its metabolite 2-chloroethanol in patients with high-grade gliomas. [electronic resource] by
- Tranchand, B
- Lucas, C
- Biron, P
- Giroux, B
- Gordon, B
- Richards, R
- Solere, P
- Roux, N
- Evene, E
- Mornex, F
Producer: 19930504
In:
Cancer chemotherapy and pharmacology vol. 32
Availability: No items available.
|
|
6.
|
Phase I and pharmacokinetic study of a novel mitomycin C analog KW-2149. [electronic resource] by
- Dirix, L
- Catimel, G
- Koier, I
- Provè, A
- Schrijvers, D
- Joossens, E
- De Bruijn, E
- Ardiet, C
- Evene, E
- Dumortier, A
Producer: 19950626
In:
Anti-cancer drugs vol. 6
Availability: No items available.
|
|
7.
|
Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors. [electronic resource] by
- Tranchand, B
- Catimel, G
- Lucas, C
- Sarkany, M
- Bastian, G
- Evene, E
- Guastalla, J P
- Négrier, S
- Rebattu, P
- Dumortier, A
- Foy, M
- Grossin, F
- Mazier, B
- Froudarakis, M
- Barbet, N
- Clavel, M
- Ardiet, C
Producer: 19980313
In:
Cancer chemotherapy and pharmacology vol. 41
Availability: No items available.
|